Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 10, 2026
Invesco S&P International Developed Quality ETF (IDHQ): Quality Focus in Developed Markets Outside the U.S.

Invesco S&P International Developed Quality ETF (IDHQ): Quality Focus in Developed Markets Outside the U.S.

Key Takeaways

  • Global economic growth expectations and interest rate trajectories in developed economies outside the U.S. represent key macro drivers for international quality equities.
  • Sector outlooks in technology, healthcare, and industrials could shape performance given the ETF’s emphasis on high-quality companies with strong return-on-equity profiles.
  • Portfolio exposure to large- and mid-cap developed-market stocks offers potential resilience through quality screening but carries geographic concentration risks in Europe and Japan.
  • ETF inflow trends and broader international equity demand may influence assets under management (AUM) as investors seek diversified non-U.S. exposure.
  • Upcoming catalysts include central bank policy decisions, corporate earnings seasons, and index rebalancing events that could affect constituent weights.
  • Structural strengths include a rules-based focus on financial quality metrics, supporting long-term positioning amid evolving market cycles.

Portfolio Exposure and ETF Strategy Overview

The IDHQ tracks the S&P Quality Developed ex-U.S. LargeMidCap Index. This index selects constituents from the S&P Developed ex-U.S. LargeMidCap Index based on a quality score derived from return on equity, accruals ratio, and financial leverage ratio. The ETF employs a passive strategy, investing at least 90% of its assets in the index’s common stocks, with semi-annual rebalancing and reconstitution.

Top holdings typically include companies such as ASML Holding NV, Roche Holding AG, and Novartis AG, with significant allocations to industrials, technology, and healthcare sectors. Geographic exposure concentrates in Europe and Japan, reflecting developed-market opportunities outside the United States. This positioning structurally favors firms demonstrating consistent profitability and prudent financial management, potentially supporting performance through economic cycles by emphasizing balance-sheet strength and earnings quality. I also checked this using Tickeron’s AI Screener to see how the holdings compare within the broader international quality space.

Major Catalysts Ahead

Interest rate decisions by the European Central Bank and Bank of Japan could affect valuations of quality-oriented international equities, as lower rates often support growth-sensitive sectors within the ETF’s holdings. Inflation trends in Europe and Asia may influence corporate margins and investor sentiment toward developed-market equities.

Earnings outlooks for major holdings in technology and healthcare will remain important, given their weight in the portfolio and sensitivity to global supply chains and innovation cycles. Policy or regulatory developments, such as trade agreements or tax reforms in key regions, could alter competitive dynamics for multinational constituents. ETF inflows or outflows, driven by investor appetite for international diversification, may also impact liquidity and AUM growth.

Sector, Index, and Macroeconomic Outlook

Broader equity market trends in developed regions outside the U.S. hinge on synchronized global growth, currency movements, and monetary policy divergence. Lower interest rates or accommodative stances could benefit quality stocks by reducing borrowing costs and supporting valuations in capital-intensive sectors like technology and industrials.

Inflation moderation may ease pressure on input costs for healthcare and consumer defensive companies within the index. Economic growth expectations in Europe and Japan, alongside equity market breadth, will likely influence the underlying S&P Quality Developed ex-U.S. LargeMidCap Index. Commodity cycles and global supply-chain stability could further affect industrials exposure, while currency fluctuations add an additional layer of sensitivity for U.S.-based investors in this international allocation.

Using the Trend Prediction Engine for Market Insights

In my research process, Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. I find it useful when assessing potential movements in international ETFs like this one, as it adds another layer of data-driven perspective to the fundamental outlook.

Long-Term Outlook and Structural Trends

Long-term sector growth in technology and healthcare, driven by innovation adoption and demographic shifts toward aging populations in developed markets, aligns with the ETF’s quality focus. Economic cycles and interest rate normalization could favor companies with strong balance sheets and consistent profitability metrics emphasized by the index methodology.

Global investment trends toward international diversification may support demand for developed ex-U.S. equities, while market structure changes such as evolving ESG considerations or regulatory frameworks could influence index composition over time. The underlying index’s emphasis on high-quality large- and mid-cap firms positions the ETF to capture structural opportunities in stable, cash-generative businesses across Europe, Japan, and other developed regions. From what I see, this rules-based approach remains a steady way to gain exposure without chasing short-term noise.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IDHQ

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


Momentum Indicator for IDHQ turns positive, indicating new upward trend

IDHQ saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IDHQ advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 291 cases where IDHQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IDHQ moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for IDHQ turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

IDHQ broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN), BHP Group Limited (NYSE:BHP), Boeing Company (NYSE:BA), Spotify Technology SA (NYSE:SPOT), Canadian Natural Resources Limited (NYSE:CNQ), Suncor Energy (NYSE:SU), Archer Daniels Midland Company (NYSE:ADM).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the S&P Quality Developed ex-U.S. LargeMidCap Index (the "underlying index"). The fund will invest at least 90% of its total assets in securities that comprise the underlying index. The index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P Developed ex-U.S. LargeMidCap Index that the index provider identifies as being of the highest quality-that is, stocks of companies that seek to generate higher revenue and cash flow than their counterparts through prudent use of assets and finances.

Market Cap

The average market capitalization across the Invesco S&P International Dev Qual ETF ETF is 59.7B. The market cap for tickers in the group ranges from 989.57K to 675.81B. ASML holds the highest valuation in this group at 675.81B. The lowest valued company is ANDR at 989.57K.

High and low price notable news

The average weekly price growth across all stocks in the Invesco S&P International Dev Qual ETF ETF was 30%. For the same ETF, the average monthly price growth was 63%, and the average quarterly price growth was 532%. MNDY experienced the highest price growth at 13%, while ROG experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Invesco S&P International Dev Qual ETF ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was 96%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 56
Price Growth Rating: 47
SMR Rating: 60
Profit Risk Rating: 59
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
IDHQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category ForeignLargeGrowth

Profile
Details
Category
Foreign Large Growth
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.